DFTX compared with SNYR: revenue, margins and what each company keeps, and the suppliers and customers both name

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

SNYRSynergy CHC Corp.

Mkt capRevenueRevenue

Compare

DFTXDefinium Therapeutics, Inc.

SNYRSynergy CHC Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DFTX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.9%0.00%×0.00

May 8 '26±9.7%▼−4.96%×0.52

Q1 FY26±12.9%▲+0.93%×0.07

Jan 12 '26—▲+0.29%—

SNYR

No earnings history for SNYR.

= impliedDFTX realized, solidSNYR realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedSource: market data

DFTXDefinium Therapeutics, Inc.

34.83▲+4.70%

Mkt cap$4.5BRevenue—Revenue—

SNYRSynergy CHC Corp.

Regular sessionNov 9 '26

Mkt cap—Revenue$5MQ1 FY26Revenue$30MFY25

Compare

Regular sessionNov 9 '26

DFTXDefinium Therapeutics, Inc.

SNYRSynergy CHC Corp.

34.83▲+4.70%

Price

$4.5B

Mkt cap

—

Revenue

$5MQ1 FY26

—

Revenue

$30MFY25

DFTX34.83▲+4.70%vsSNYRRegular sessionNov 9 '26